表紙
市場調查報告書

核酸的分離、純化的全球市場:2017年∼2021年

Global Nucleic Acid Isolation and Purification Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 586147
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
核酸的分離、純化的全球市場:2017年∼2021年 Global Nucleic Acid Isolation and Purification Market 2017-2021
出版日期: 2017年11月27日內容資訊: 英文 107 Pages
簡介

關於核酸的分離、純化

分離和純化核酸,脫氧核糖核酸(DNA)和核糖核酸(RNA)是分子生物學中使用的基本技術。這些生物分子可以從任何生物材料中分離出來用於下游、分析或製備目的。在研究實驗室和工業中對DNA指紋圖譜,基因組或測序庫的構建,限制性片段長度多態性(RFLP)和聚合酶鍊式反應(PCR)分析的需求增加。此外,核酸分離和純化是研究特定的DNA和RNA序列以及分析基因組結構和基因表達的第一步。然而,核酸的數量,質量和完整性將直接影響這些結果。

Technavio的分析師預測,從2017年到在2021年之間,全球核酸分離、純化市場將以8.33%的年複合成長率成長。

本報告提供全球核酸分離、純化市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 簡介

  • 市場概要

第5章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第6章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模及預測

第7章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入企業的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第8章 市場劃分:各終端用戶

  • 市場區隔:各終端用戶
  • 比較:各終端用戶
  • 學術研究機關
  • 製藥、生物科技企業
  • 其他
  • 市場機會:各終端用戶

第9章 地理分割

  • 各地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 推銷活動的重要性增加
  • 為了推動分子生物學研究的配合措施擴大
  • 自動化產品的可用性提高

第13章 供應商情形

  • 競爭模式
  • 投資機會

第14章 供應商分析

  • 供應商概要
  • Agilent Technologies
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Thermo Fisher Scientific
  • 其他有力的供應商

第15章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR15900

About Nucleic Acid Isolation and Purification

Isolation and purification of nucleic acids, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), is the basic technique used in molecular biology. These biomolecules can be isolated from any biological material for consequent downstream, analytical, or preparative purposes. The demand for DNA fingerprinting, construction of genomic or sequencing libraries, restriction fragment length polymorphism (RFLP), and polymerase chain reaction (PCR) analysis in research laboratories and industries has increased. Also, nucleic acid isolation and purification is the first step in the study of specific DNA and RNA sequences, and in the analysis of genome structure and gene expression. However, the quantity, quality, and integrity of nucleic acids will directly affect these results.

Technavio's analysts forecast the global nucleic acid isolation and purification market to grow at a CAGR of 8.33% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global nucleic acid isolation and purification market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Nucleic Acid Isolation and Purification Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • F.Hoffmann-La-Roche
  • GE Healthcare
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Abcam
  • Bioline
  • biotechrabbit
  • bioWORLD
  • Danaher
  • Epicentre
  • Hamilton
  • New England Biolabs
  • Omega Bio-tek
  • Promega
  • Qiagen
  • Sigma-Aldrich
  • Takara Bio

Market driver

  • Increasing occurrence of genetic disorder, cancer, and infectious diseases
  • For a full, detailed list, view our report

Market challenge

  • Intense competition between local and global vendors
  • For a full, detailed list, view our report

Market trend

  • Increasing importance of promotional activities
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2016
  • Market size and forecast 2016-2021

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Comparison by end-user
  • Academic and research institutes
  • Pharmaceutical and biotechnology companies
  • Others
  • Market opportunity by end-user

PART 09: GEOGRAPHICAL SEGMENTATION

  • Geographical segmentation
  • Regional comparison
  • Americas
  • EMEA
  • APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing importance of promotional activities
  • Increase in initiatives to promote molecular research
  • Increased availability of automated products

PART 13: VENDOR LANDSCAPE

  • Competitive scenario
  • Investment opportunity

PART 14: VENDOR ANALYSIS

  • Vendor overview
  • Agilent Technologies
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global nucleic acid isolation and purification market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition: Inclusions and exclusions checklist
  • Exhibit 06: Market size 2016
  • Exhibit 07: Validation techniques employed for market sizing 2016
  • Exhibit 08: Global nucleic acid isolation and purification market 2016-2021 ($ mn)
  • Exhibit 09: Global nucleic acid isolation and purification market: Year-over-year growth 2017-2021 (%)
  • Exhibit 10: Five forces analysis 2016
  • Exhibit 11: Five forces analysis 2021
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition: Five forces 2016
  • Exhibit 18: Market condition: Five forces 2021
  • Exhibit 19: Global nucleic acid isolation and purification market by end-user 2016-2021 (%)
  • Exhibit 20: Comparison by end-user
  • Exhibit 21: Global nucleic acid isolation and purification market by academic and research institutes 2016-2021 ($ mn)
  • Exhibit 22: Global nucleic acid isolation and purification market by academic and research institutes: Year-over-year growth 2017-2021 (%)
  • Exhibit 23: Global nucleic acid isolation and purification market by pharmaceutical and biotechnology companies 2016-2021 ($ mn)
  • Exhibit 24: Global nucleic acid isolation and purification market by pharmaceutical and biotechnology companies: Year-over-year growth 2017-2021 (%)
  • Exhibit 25: Global nucleic acid isolation and purification market by others 2016-2021 ($ mn)
  • Exhibit 26: Global nucleic acid isolation and purification market by others: Year-over-year growth 2017-2021 (%)
  • Exhibit 27: Market opportunity by end-user
  • Exhibit 28: Global nucleic acid isolation and purification market 2016-2021
  • Exhibit 29: Regional comparison
  • Exhibit 30: Nucleic acid isolation and purification market in Americas 2016-2021 ($ mn)
  • Exhibit 31: Nucleic acid isolation and purification market in Americas: Year-over-year growth 2017-2021 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: Nucleic acid isolation and purification market in EMEA 2016-2021 ($ mn)
  • Exhibit 34: Nucleic acid isolation and purification market in EMEA: Year-over-year growth 2017-2021 ($ mn)
  • Exhibit 35: Top 3 countries in EMEA
  • Exhibit 36: Nucleic acid isolation and purification market in APAC 2016-2021 ($ mn)
  • Exhibit 37: Nucleic acid isolation and purification market in APAC: Year-over-year growth
  • Exhibit 38: Top 3 countries in APAC
  • Exhibit 39: Strategic success factors for vendors
  • Exhibit 40: Investment opportunity mapping
  • Exhibit 41: Agilent Technologies: Profile
  • Exhibit 42: Agilent Technologies: Strength analysis
  • Exhibit 43: Agilent Technologies: Strategy assessment
  • Exhibit 44: Agilent Technologies: Opportunity assessment
  • Exhibit 45: Bio-Rad Laboratories: Profile
  • Exhibit 46: Bio-Rad Laboratories: Strength analysis
  • Exhibit 47: Bio-Rad Laboratories: Strategy assessment
  • Exhibit 48: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 49: F. Hoffmann-La Roche: Profile
  • Exhibit 50: F. Hoffmann-La Roche: Strength analysis
  • Exhibit 51: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 52: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 53: GE Healthcare: Profile
  • Exhibit 54: GE Healthcare: Strength analysis
  • Exhibit 55: GE Healthcare: Strategy assessment
  • Exhibit 56: GE Healthcare: Opportunity assessment
  • Exhibit 57: Thermo Fisher Scientific: Profile
  • Exhibit 58: Thermo Fisher Scientific: Strength analysis
  • Exhibit 59: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 60: Thermo Fisher Scientific: Opportunity assessment